333 related articles for article (PubMed ID: 29227930)
21. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
Zhang T; Shen W; Liu M; Zhang R; Wang M; Li L; Wang B; Guo H; Lu Y
Eur J Med Chem; 2015 Nov; 104():73-85. PubMed ID: 26435513
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
24. Benzofuran-isatin-imine hybrids tethered via different length alkyl linkers: Design, synthesis and in vitro evaluation of anti-tubercular and anti-bacterial activities as well as cytotoxicity.
Gao F; Wang T; Gao M; Zhang X; Liu Z; Zhao S; Lv Z; Xiao J
Eur J Med Chem; 2019 Mar; 165():323-331. PubMed ID: 30690301
[TBL] [Abstract][Full Text] [Related]
25. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of 1H-1,2,3-triazole linked β-lactam-isatin bi-functional hybrids and preliminary analysis of in vitro activity against the protozoal parasite Trichomonas vaginalis.
Raj R; Singh P; Haberkern NT; Faucher RM; Patel N; Land KM; Kumar V
Eur J Med Chem; 2013 May; 63():897-906. PubMed ID: 23631874
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
28. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
Kim S; Cho SN; Oh T; Kim P
Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
[TBL] [Abstract][Full Text] [Related]
30. Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant
Elsayed ZM; Eldehna WM; Abdel-Aziz MM; El Hassab MA; Elkaeed EB; Al-Warhi T; Abdel-Aziz HA; Abou-Seri SM; Mohammed ER
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):384-393. PubMed ID: 33406941
[TBL] [Abstract][Full Text] [Related]
31. Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies.
Reddyrajula R; Dalimba U; Madan Kumar S
Eur J Med Chem; 2019 Apr; 168():263-282. PubMed ID: 30822714
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro antimycobacterial activity of 8-OCH(3) ciprofloxacin methylene and ethylene isatin derivatives.
Feng LS; Liu ML; Zhang S; Chai Y; Wang B; Zhang YB; Lv K; Guan Y; Guo HY; Xiao CL
Eur J Med Chem; 2011 Jan; 46(1):341-8. PubMed ID: 21146257
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
34. Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity.
Sirim MM; Krishna VS; Sriram D; Unsal Tan O
Eur J Med Chem; 2020 Feb; 188():112010. PubMed ID: 31893548
[TBL] [Abstract][Full Text] [Related]
35. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of α-ketotriazoles and α,β-diketotriazoles as inhibitors of Mycobacterium tuberculosis.
Menendez C; Rodriguez F; Ribeiro AL; Zara F; Frongia C; Lobjois V; Saffon N; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2013 Nov; 69():167-73. PubMed ID: 24016834
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
Dadlani VG; Chhabhaiya H; Somani RR; Tripathi PK
Chem Biol Drug Des; 2022 Aug; 100(2):230-244. PubMed ID: 35434882
[TBL] [Abstract][Full Text] [Related]
38. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
[TBL] [Abstract][Full Text] [Related]
39. Triazole derivatives and their anti-tubercular activity.
Zhang S; Xu Z; Gao C; Ren QC; Chang L; Lv ZS; Feng LS
Eur J Med Chem; 2017 Sep; 138():501-513. PubMed ID: 28692915
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents.
Türe A; Kulabaş N; Dingiş Sİ; Birgül K; Bozdeveci A; Alpay Karaoğlu Ş; Krishna VS; Sriram D; Küçükgüzel İ
Bioorg Chem; 2019 Jul; 88():102965. PubMed ID: 31085371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]